For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 23, 2025  3 hours, 46 minutes ago

COVID-19 Can Cause Costochondritis and Tietze Syndrome

7206 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 Can Cause Costochondritis and Tietze Syndrome
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 23, 2025  3 hours, 46 minutes ago
Medical News: The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has revealed a spectrum of complications beyond respiratory illness, including musculoskeletal conditions like costochondritis and Tietze syndrome. These conditions, though distinct, share similarities and can significantly impact quality of life if not identified and treated promptly. This Medical News report explores what costochondritis and Tietze syndrome are, their symptoms, the consequences of delayed treatment, and how COVID-19 may trigger them.


 
What is Costochondritis and Tietze Syndrome?
Costochondritis is an inflammatory condition affecting the cartilage connecting the ribs to the sternum (breastbone), known as the costochondral junction. It is often characterized by localized chest pain that can mimic cardiac issues, leading to diagnostic challenges. The condition is typically self-limiting but can persist or recur if underlying causes are not addressed.
 
Tietze syndrome, a rarer condition, is similar but distinguished by visible swelling at the costochondral junction, often involving the second or third ribs. Unlike costochondritis, which is purely inflammatory, Tietze syndrome includes both inflammation and palpable swelling. Both conditions are benign but can cause significant discomfort and anxiety due to their chest pain symptoms.
 
Symptoms of Costochondritis and Tietze Syndrome
The hallmark symptom of both conditions is chest pain, which is typically sharp, aching, or pressure-like and localized to the chest wall. In costochondritis, the pain is often felt at the junction of the ribs and sternum and may radiate to the arms or shoulders. It is usually exacerbated by movement, deep breathing, coughing, or pressure on the affected area. Patients may also experience tenderness when pressing on the costochondral junctions.
 
Tietze syndrome presents similarly but is marked by visible swelling or a palpable mass at the affected site, which is absent in costochondritis. The pain may worsen with physical activity, stress, or even weather changes. Both conditions can lead to secondary symptoms like fatigue, anxiety, or difficulty breathing due to pain-related restrictions in chest expansion.
 
How COVID-19 Triggers These Conditions
COVID-19 is known to cause widespread inflammation through a cascade of immune responses, including the release of pro-inflammatory cytokines like IL-6 and TNF-α. This systemic inflammation can affect musculoskeletal tissues, including the costochondral cartilage. The virus’s impact on the respiratory system, coupled with persistent coughing in some patients, may mechanically stress the chest wall, contributing to inflammation in the costochondral junctions.
 
Additionally, COVID-19’s potential to induce autoimmune responses may play a role. Some studies suggest that the virus can trigger immune-mediated conditions, where the body’s immune system attacks its own tissues, including cartilage. Post-viral inflammatory syndromes, often seen in long COVID, may also perpetuate or exacerbate conditions like costochondritis and Tietze syndrome.
 
While the exact mechanisms are still under investigation, the combination of direct viral effects, immune dysregulation, and mechanical stress from coughing or respiratory distress likely contributes.
 
Consequences of Untreated Costochondritis and Tietze Syndrome
If not identified and treated in time, costochondritis and Tietze syndrome can lead to significant complications:
 
-Chronic Pain and Disability: Persistent inflammation can result in chronic chest pain, limiting physical activity and affecting daily life. This can lead to reduced mobility, muscle weakness, and decreased quality of life.
 
-Misdiagnosis and Delayed Treatment: The chest pain associated with these conditions can mimic serious conditions like myocardial infarction or pulmonary embolism. Misdiagnosis may lead to unnecessary tests or delayed treatment, increasing patient anxiety and healthcare costs.
 
-Psychological Impact: Chronic pain and uncertainty about the cause can contribute to anxiety, depression, or fear of serious illness, particularly given the overlap with cardiac symptoms.
 
-Secondary Complications: Prolonged inflammation may lead to cartilage damage or, in rare cases, infections in the affected area. In Tietze syndrome, persistent swelling may cause cosmetic concerns or discomfort.
 
Diagnosis and Treatment
Diagnosing costochondritis and Tietze syndrome involves a thorough clinical evaluation, including a physical exam to assess tenderness and swelling. Imaging, such as X-rays or MRI, may be used to rule out other conditions. Laboratory tests can help identify underlying inflammatory or autoimmune markers, particularly in COVID-19-related cases.
 
Treatment typically includes nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation, along with rest and avoidance of activities that exacerbate symptoms. In severe cases, corticosteroid injections or physical therapy may be recommended. For COVID-19-related cases, addressing underlying inflammation with targeted therapies, such as low-dose steroids or immune-modulating drugs, may be considered under medical supervision. Patients are also advised to manage stress and avoid excessive coughing or strenuous activity.
 
Preventive Measures and Outlook
Early recognition of symptoms is crucial, particularly in post-COVID-19 patients. Healthcare providers should consider costochondritis or Tietze syndrome in patients presenting with chest pain after COVID-19, especially if cardiac and pulmonary causes are ruled out. Patient education about these conditions can reduce anxiety and promote timely treatment.
 
With proper management, most patients recover fully within weeks to months. However, in the context of COVID-19, ongoing monitoring for long-term complications or recurrence is essential, given the virus’s unpredictable effects on the body.
 
References:
https://www.tandfonline.com/doi/full/10.1080/08998280.2021.1973274
 
https://ada.com/covid/covid-19-costochondritis/
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC10564091/
 
https://onlinelibrary.wiley.com/doi/10.1002/pmrj.13098
 
https://www.cureus.com/articles/145804-tietze-syndrome-as-a-cause-of-chest-pain-in-the-post-covid-19-period#!/
 
https://www.sciencedirect.com/science/article/pii/S2589790X21002201
 
https://www.has-sante.fr/upload/docs/application/pdf/2022-10/chest_pain_toolkit_guide.pdf
 
https://www.journaladvancedultrasound.com/EN/10.37015/AUDT.2025.240029
 
https://link.springer.com/article/10.1007/s11239-023-02808-8
 
By understanding the link between COVID-19, costochondritis, and Tietze syndrome, patients and healthcare providers can better address these conditions, ensuring timely intervention and improved outcomes.
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/articles/coronavirus
 

MOST READ

Oct 20, 2025  3 days ago
Nikhil Prasad
Oct 17, 2025  6 days ago
Nikhil Prasad
Oct 14, 2025  9 days ago
Nikhil Prasad
Oct 12, 2025  11 days ago
Nikhil Prasad
Oct 07, 2025  16 days ago
Nikhil Prasad
Sep 27, 2025  26 days ago
Nikhil Prasad
Sep 22, 2025  1 month ago
Nikhil Prasad
Sep 17, 2025  1 month ago
Nikhil Prasad
Sep 16, 2025  1 month ago
Nikhil Prasad
Sep 10, 2025  1 month ago
Nikhil Prasad